Great Valley Advisor Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
|
|||||
|
2025
Q1 | $223K | Sell |
|
|||||
|
2024
Q4 | $260K | Sell |
|
|||||
|
2024
Q3 | $337K | Buy |
|
|||||
|
2024
Q2 | $247K | Sell |
|
|||||
|
2024
Q1 | $306K | Buy |
|
|||||
|
2023
Q4 | $224K | Sell |
|
|||||
|
2023
Q3 | $370K | Buy |
|
|||||
|
2023
Q2 | $383K | Buy |
|
|||||
|
2023
Q1 | $268K | Buy |
|
|||||
|
2022
Q4 | $257K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $273K | Sell |
|
|||||
|
2021
Q3 | $367K | Sell |
|
|||||
|
2021
Q2 | $445K | Sell |
|
|||||
|
2021
Q1 | $596K | Sell |
|
|||||
|
2020
Q4 | $917K | Buy |
|
|||||
|
2020
Q3 | $378K | Sell |
|
|||||
|
2020
Q2 | $1.17M | Buy |
|
|||||
|
2020
Q1 | $373K | Buy |
|